165885 20260115140311.0 doi 10.22465/juo.255000080004 sideral 147428 ART-2025-147428 eng Sanz del Pozo, Mónica Universidad de Zaragoza Expression and Prognostic Value of VEGF, VEGFR1, VEGFR2, VEGFR3, and E-Cadherin in Clear Cell Renal Cell Carcinoma 2025 Purpose: Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype of renal carcinoma, accounting for 75%–80% of cases. Vascular endothelial growth factor (VEGF), which promotes angiogenesis via its membrane receptors (VEGFRs), and E-cadherin, which decreases in expression during invasion and metastasis, are both implicated in ccRCC pathogenesis. We analyzed the relationship between these proteins and ccRCC lesions to assess their usefulness as prognostic markers.Materials and Methods: Renal tumor tissue samples from nephrectomies of 69 patients were analyzed using immunohistochemical techniques to evaluate the expression of the aforementioned proteins. These findings were then compared with established prognostic scales. Statistical analysis was performed using SPSS Statistics ver. 29.0.1.0.Results: VEGF intensity was significantly correlated with tumor size (T; p=0.002), stage (p<0.001), and metastasis (M; p=0.049) according to the TNM classification. VEGFR3 expression correlated positively with tumor size (T; p=0.046) and stage (p=0.040). E-cadherin expression correlated negatively with tumor size (p=0.047). In relation to prognostic scales, VEGF expression correlated with the UCLA Integrated Staging System score (p=0.009), while E-cadherin correlated with the stage, size, grade and necrosis (SSIGN) score (p=0.044). For both overall and disease-free survival, significant differences were observed between the moderate (2++) and intense (3+++) VEGFR3 intensity groups (p=0.009 for both).Conclusion: VEGF may have prognostic value due to its association with tumor size, stage, metastasis, and the UCLA Integrated Staging System score. Similarly, VEGFR3 shows prognostic potential based on its correlations with tumor size, stage, and its relation to overall and disease-free survival. E-cadherin also demonstrates prognostic significance through its association with tumor size and the SSIGN score. Access copy available to the general public Unrestricted info:eu-repo/semantics/openAccess by-nc https://creativecommons.org/licenses/by-nc/4.0/deed.es info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Gimeno Pelegrín, Joaquín Universidad de Zaragoza Rodriguez Muñoz, Nebay Utrilla Berberana, Diana Bascuas Hernandez, Javier López del Val, Alejandro Gómez Barrera, Manuel Azúa Romeo, Javier Capapé Poves, Victoria Universidad de Zaragoza Borque Fernando, Ángel Universidad de Zaragoza (orcid)0000-0003-0178-4567 Sánchez Zalabardo, José Manuel (orcid)0000-0002-2328-9236 Sáez Gutiérrez, Berta (orcid)0000-0003-2627-5953 1007 610 Universidad de Zaragoza Dpto. Medicina, Psiqu. y Derm. Area Medicina 1013 817 Universidad de Zaragoza Dpto. Cirugía Área Urología 23, 2 (2025), 132-139 JUO Journal of Urologic Oncology 2951-603X 554502 http://zaguan.unizar.es/record/165885/files/texto_completo.pdf Versión publicada 2432570 http://zaguan.unizar.es/record/165885/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:165885 articulos driver 2026-01-15-12:37:17 ARTICLE